TY - JOUR AU - Moschen, R. AU - Kühl, N. AU - Peters, S. AU - Vos, H. AU - Lücke, A. TI - Temperature variability at Dürres Maar, Germany, during the Migration Period and at High Medieval Times, inferred from stable carbon isotopes of Sphagnum cellulose JO - Climate of the past VL - 7 SN - 1814-9332 CY - Katlenburg-Lindau PB - Copernicus Ges. M1 - PreJuSER-17017 SP - 1011 - 1026 PY - 2011 N1 - We thank Georg Heumann, Thomas Litt, Jorn Parplies and Nils Riedel for assistance in the field. The help of Stefanie Wagner during core sampling is greatly acknowledged. Stable isotope measurements were carried out by Holger Wissel at the Institute of Bio- and Geosciences, Agrosphere. This work was supported by a grant of the Deutsche Forschungsgemeinschaft (German Research Foundation) to Robert Moschen (grant MO 1401/2-2). AB - To assess the risk and identify risk factors of Hodgkin lymphoma (HL) in solid organ transplant recipients. Prior research has been limited by the rarity of HL and the requirement for extended follow-up after transplantation.Using data from the Scientific Registry of Transplant Recipients (SRTR), we conducted a retrospective cohort study of US solid organ transplant recipients (1997-2007). We estimated hazard ratios (HRs) for HL risk factors using proportional hazards regression. Standardized incidence ratios (SIRs) compared HL risk in the transplant cohort with the general population.The cohort included 283,190 transplant recipients (average follow-up: 3.7 years after transplantation). Based on 73 cases, HL risk factors included male gender (HR: 2.1, 95% CI: 1.2-3.7), young age (4.0, 2.3-6.8), and Epstein-Barr virus (EBV) seronegativity at the time of transplantation (3.1, 1.2-8.1). Among tumors with EBV status information, 79% were EBV positive, including all tumors in recipients who were initially seronegative. Overall, HL risk was higher than in the general population (SIR: 2.2) and increased monotonically over time after transplantation (SIR: 4.1 at 8-10 years posttransplant). Excess HL risk was especially high after heart and/or lung transplantation (SIR: 3.2).HL is a late complication of solid organ transplantation. The high HL risk in recipients who were young or EBV seronegative at the time of transplant and the fact that most HL tumors were EBV positive highlight the role of primary EBV infection and poor immune control of this virus. The occurrence of HL may rise with improved long-term survival in transplant recipients. KW - Adolescent KW - Adult KW - Child KW - Cohort Studies KW - Female KW - Follow-Up Studies KW - Hodgkin Disease: epidemiology KW - Humans KW - Incidence KW - Male KW - Middle Aged KW - Organ Transplantation: adverse effects KW - Proportional Hazards Models KW - Retrospective Studies KW - Risk Factors KW - Time Factors KW - United States KW - J (WoSType) LB - PUB:(DE-HGF)16 C6 - pmid:20733533 C2 - pmc:PMC2967618 UR - <Go to ISI:>//WOS:000295356800023 DO - DOI:10.5194/cp-7-1011-2011 UR - https://juser.fz-juelich.de/record/17017 ER -